Ata uhi

Pharmacovigilance: Curriculum and career

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi matua:	Bhaswat S Chakraborty (Author)
Hōputu:	Pukapuka
I whakaputaina:	Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Clinical Research in India: The current scenario and prospects
mā: Bhaswat S Chakraborty
I whakaputaina: (2013)

Design of experiments: A design to improve pharmaceutical research
mā: Bhaswat S Chakraborty
I whakaputaina: (2023)

A Longitudinal Career Development Curriculum
mā: Anita Pokorny
I whakaputaina: (2009)

Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey
mā: Yalan Tang, me ētahi atu.
I whakaputaina: (2023)

Application of critical path analysis in clinical trials
mā: Amal Kumar, me ētahi atu.
I whakaputaina: (2016)

Interim analysis: A rational approach of decision making in clinical trial
mā: Amal Kumar, me ētahi atu.
I whakaputaina: (2016)

Construct Interdisciplinary Curriculum by Career Interest Code Within Major for Multiple Career Paths
mā: Su-Fei Huang
I whakaputaina: (2014)

The research activity in the curriculum project of Plan D of the Stomatology career.
mā: Sol Ángel Rosales Reyes, me ētahi atu.
I whakaputaina: (2014)

Pharmacovigilance
I whakaputaina: (2019)

An Interprofessional Curriculum to Advance Relational Coordination and Professionalism in Early-Career Practitioners
mā: Katherine B. Valenziano, me ētahi atu.
I whakaputaina: (2018)

Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
mā: A. E. Krasheninnikov, me ētahi atu.
I whakaputaina: (2021)

Pharmacovigilance Volume 2
I whakaputaina: (2023)

ON THE SUBJECT OF PHARMACOVIGILANCE
mā: M. A. Murashko
I whakaputaina: (2015)

ON THE SUBJECT OF PHARMACOVIGILANCE
mā: M. A. Murashko
I whakaputaina: (2015)

ON THE SUBJECT OF PHARMACOVIGILANCE
mā: M. A. Murashko
I whakaputaina: (2015)

Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
mā: N. Yu. Velts, me ētahi atu.
I whakaputaina: (2023)

Literature Monitoring for Pharmacovigilance
mā: A. G. Khudoshin, me ētahi atu.
I whakaputaina: (2019)

Terms recommended for pharmacovigilance
mā: B. K. Romanov
I whakaputaina: (2018)

Pharmacovigilance Programme of India
mā: Duvvuru Ashok Kumar, me ētahi atu.
I whakaputaina: (2015)

Pharmacovigilance programme of India
mā: Kalaiselvan Vivekanandan, me ētahi atu.
I whakaputaina: (2012)

Automated pharmacovigilance system
mā: O. A. Loginovskaya, me ētahi atu.
I whakaputaina: (2018)

Students and academicians views on the engineering curriculum and industrial skills requirement for a successful job career
mā: Gope Deepayan, me ētahi atu.
I whakaputaina: (2022)

Nurturing Peer Review Proficiency in the Curriculum for Early Career Medical Researchers: Fostering Academic Connectivity
mā: Amit Kumar, me ētahi atu.
I whakaputaina: (2024)

Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
mā: Abimbola O. Opadeyi, me ētahi atu.
I whakaputaina: (2018)

Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
mā: Ambrose O. Isah, me ētahi atu.
I whakaputaina: (2023)

Pharmacovigilance: Scope for a dermatologist
mā: Bhanu Prakash, me ētahi atu.
I whakaputaina: (2011)

PARTICULARITIES OF PHARMACOVIGILENCE ACTIVITY IN DENTISTRY
mā: Ioana Maria Hunea, me ētahi atu.
I whakaputaina: (2019)

Evaluation of Pharmacovigilance System in Iran
mā: Malahat Khalili, me ētahi atu.
I whakaputaina: (2022)

Pharmacoenvironmentology - a component of pharmacovigilance
mā: Gupta Varun, me ētahi atu.
I whakaputaina: (2007)

Pharmacovigilance: Empowering healthcare professionals
mā: Mugoša Snežana S., me ētahi atu.
I whakaputaina: (2015)

Pharmacovigilance system in Saudi Arabia
mā: Thamir M. Alshammari, me ētahi atu.
I whakaputaina: (2017)

An update on the Pharmacovigilance Programme of India
mā: Ratan J Lihite, me ētahi atu.
I whakaputaina: (2015)

Herbal medicines pharmacovigilance in Iran
mā: Mohammad Hadi Zarei
I whakaputaina: (2022)

Pharmacovigilance on cannabidiol as an antiepileptic agent
mā: Ilaria Ammendolia, me ētahi atu.
I whakaputaina: (2023)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
mā: E. O. Zhuravleva, me ētahi atu.
I whakaputaina: (2018)

Preparation for the Inspection of the Pharmacovigilance System
mā: B. K. Romanov
I whakaputaina: (2021)

Assessment of Pharmacovigilance Reporting in Russia
mā: Yu. V. Olefir, me ētahi atu.
I whakaputaina: (2018)

Methods of working with pharmacovigilance signals
mā: O. A. Loginovskaya, me ētahi atu.
I whakaputaina: (2018)

Era of pharmacovigilance: Revolution in healthcare
mā: Upendra Nagaich
I whakaputaina: (2015)

A Facilitated Peer Mentoring Program With a Dedicated Curriculum to Foster Career Advancement of Academic Hospitalists
mā: Doris Lin, me ētahi atu.
I whakaputaina: (2023)